Neuronetics Inc (STIM)
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’sPersonalized Care Trial Program
Lantheus Holdings Inc. (LNTH)
Lantheus to Present at the 2025 Truist Securities MedTech Conference
Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor
Day One Biopharmaceuticals Inc (DAWN)
Day One Appoints Michael Vasconcelles, M.D., as Headof Research and Development
Insulet Corporation (PODD)
Insulet - Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
Vivani Medical Inc. (VANI)
Vivani Medical to Present at the 2025 BIO International Convention
Oragenics Inc. (OGEN)
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
Gain Therapeutics Inc. (GANX)
Gain Therapeutics to Participate in Upcoming Investor Conferences
Outlook Therapeutics Inc. (OTLK)
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Novo Nordisk (NVO)
ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care